MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-38

  1. 764 Posts.
    lightbulb Created with Sketch. 117
    "Meeting with FDA, expected within 30 days, to discuss a potential accelerated approval with a post-approval condition for an additional study."
    When you read it, the FDA could approve the treatment with the condition of an additional study. Not as bad as first presented!!!!! Could be approved soon with conditional study! that's my take on it. Buy in cheap!!!!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.